Euroespes S.A. (EEP) - Cash Flow Conversion Efficiency

Latest as of December 2022: 0.003x

Based on the latest financial reports, Euroespes S.A. (EEP) has a cash flow conversion efficiency ratio of 0.003x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€16.87K ≈ $19.72K USD) by net assets (€6.20 Million ≈ $7.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Euroespes S.A. - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Euroespes S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Euroespes S.A. (EEP) total liabilities for a breakdown of total debt and financial obligations.

Euroespes S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Euroespes S.A. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
CodeLab Capital A/S
OL:CODE
N/A
Codrus Minerals Ltd
AU:CDR
-0.465x
Cre8 Enterprise Limited Class A Ordinary Shares
NASDAQ:CRE
0.155x
Halfords Group PLC
LSE:HFD
0.193x
Indaptus Therapeutics Inc
NASDAQ:INDP
-0.663x
International Lithium Corp
V:ILC
-0.028x
Inix Technologies Holdings Bhd
KLSE:0094
0.015x
Jet.AI Inc.
NASDAQ:JTAI
0.031x

Annual Cash Flow Conversion Efficiency for Euroespes S.A. (2010–2024)

The table below shows the annual cash flow conversion efficiency of Euroespes S.A. from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Euroespes S.A..

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €2.57 Million
≈ $3.01 Million
€70.53K
≈ $82.45K
0.027x -85.74%
2023-12-31 €2.89 Million
≈ $3.38 Million
€556.08K
≈ $650.12K
0.192x +284.10%
2022-12-31 €6.20 Million
≈ $7.25 Million
€-647.82K
≈ $-757.37K
-0.104x -4775.18%
2021-12-31 €7.43 Million
≈ $8.68 Million
€16.60K
≈ $19.41K
0.002x +105.78%
2020-12-31 €7.44 Million
≈ $8.70 Million
€-287.52K
≈ $-336.15K
-0.039x +43.58%
2019-12-31 €7.45 Million
≈ $8.71 Million
€-510.28K
≈ $-596.57K
-0.068x -1425.55%
2018-12-31 €8.80 Million
≈ $10.29 Million
€45.47K
≈ $53.16K
0.005x -97.41%
2017-12-31 €4.57 Million
≈ $5.34 Million
€911.75K
≈ $1.07 Million
0.200x +88.63%
2016-12-31 €4.26 Million
≈ $4.98 Million
€451.25K
≈ $527.55K
0.106x -21.39%
2015-12-31 €3.08 Million
≈ $3.60 Million
€414.91K
≈ $485.07K
0.135x +302.30%
2014-12-31 €2.75 Million
≈ $3.21 Million
€91.88K
≈ $107.42K
0.033x +45.12%
2010-12-31 €3.98 Million
≈ $4.66 Million
€91.88K
≈ $107.42K
0.023x --

About Euroespes S.A.

MC:EEP Spain Diagnostics & Research
Market Cap
$4.61 Million
€3.95 Million EUR
Market Cap Rank
#28794 Global
#210 in Spain
Share Price
€0.34
Change (1 day)
+0.00%
52-Week Range
€0.34 - €0.54
All Time High
€1.26
About

Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. It offers personalized and genomic medicine services for predictive, diagnostic, and therapeutic purposes. The company also provides medical services, such as neuro-ophthalmology, neuro-otorhinolaryngology, neu… Read more